Anzeige
Mehr »
Dienstag, 10.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
54 Leser
Artikel bewerten:
(0)

Global Flow Cytometry Market, 2025 - Research and Markets

DUBLIN, Apr. 13, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Flow Cytometry Market Analysis By Technology (Cell-Based, Bead-Based), By Application (Research, Industrial, Clinical), By End-use (Commercials, Hospitals, Academics, Clinical Labs), By Product & Services, And Segment Forecasts, 2014 - 2025" report to their offering.

Research and Markets Logo

The global flow cytometry market is expected to reach USD 8.0 billion by 2025

The increasing incidence of infectious diseases and cancer is expected to upsurge the demand for flow cytometers for use in disease diagnosis over the coming years. In addition, higher number of physicians is inclined toward the usage of autologous and allogenic stem cell therapy, due to adverse effects caused by chemotherapy & radiation therapy in the treatment of cancer, thereby affecting the growth of this market.

Moreover, rising demand for point-of-care testing in chronic diseases management is expected to fuel the demand for cytometry techniques. Rising implementation of microfluidic miniature flow cytometry in point-of-care diagnostics is the factor augmenting the future growth. Increasing R&D initiatives by various key players for the development of multicolor assays and advanced reagents for analysis are anticipated to boost the usage rate. Advancement in technology for the purpose of enhanced accuracy, portability, and cost-effectiveness is expected to serve this market with lucrative growth opportunities.

Small-size high-throughput cytometers are expected to gain popularity over the coming years due to associated benefits such as ease in use and cost-effectiveness. Furthermore, improvement in fluorescent dyes & introduction of bench top cytometers are the other growth propellers. For instance, multicolor flow cytometry coupled with multiple lasers is the fastest growing application segment, which finds extensive applications in the field of R&D innovations in new drug development and is adopted by many contract research organizations.

Further Key Findings From the Study Suggest:

  • Bead-based flow cytometry is anticipated to witness lucrative growth rate over the forecast period owing to increasing advancement in molecular engineering & monoclonal antibody production
  • Reagents & consumables are expected to be the fastest growing segment as of 2016 due to extensive utilization in molecular diagnostics
  • Clinical diagnosis market is driven by factors such as increasing demand for cost-effective disease diagnosis and associated benefits of these assays in disease detection
  • The largest market share of commercial organizations can be attributed to the rising large-scale production of proteins, cell line development, and other biologicals coupled with the growing demand for cell sorting and analysis techniques
  • Asia Pacific regional market is presumed to witness the fastest growth owing to increasing supportive government initiatives for flourishing biotech industry coupled with growing awareness about the applications of flow cytometers
  • Multinational players collaborating with local diagnostic companies and healthcare institutions in developing countries such as India & Brazil, target the disease population and are expected to increase market penetration

Key Topics Covered

1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.2 Region Based Segment Share Calculation
1.3 List of Secondary Sources

2 Executive Summary
2.1 Market Snapshot

3 Flow Cytometry Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Penetration & Growth Prospect Mapping
3.3 Flow Cytometry - PESTLE Analysis
3.4 Industry Analysis - Porter's

4 Flow Cytometry: Technology Estimates & Trend Analysis
4.1 Flow Cytometry Market: Technology Movement Analysis
4.2 Cell-Based
4.3 Bead based

5 Flow Cytometry: Product & Services Estimates & Trend Analysis
5.1 Flow cytometry Market: Product & Services Movement Analysis
5.2 Instruments
5.3 Reagents & Consumables
5.4 Software
5.5 Accessories
5.6 Services

6 Flow Cytometry: Application Estimates & Trend Analysis
6.1 Flow cytometry Market: Applications Movement Analysis
6.2 Research
6.3 Industrial
6.4 Clinical

7 Flow Cytometry: End-use Estimates & Trend Analysis
7.1 Flow cytometry Market: End-use Movement Analysis
7.2 Commercial Organizations
7.3 Academic Institutes

8 Flow Cytometry: Regional Estimates & Trend Analysis, by Application

9 Competitive Landscape

  • Danaher Corporation
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Sysmex Corporation
  • Agilent Technologies
  • Merck & Co., Inc.,
  • Apogee Flow Systems
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Stratedigm
  • Luminex Corporation
  • Miltenyi Biotec
  • GE Healthcare

For more information about this report visit http://www.researchandmarkets.com/research/f47vmw/flow_cytometry

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

© 2017 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.